stockrow
Friday 6 November 2026
Export ABVX’s income statement to Excel — free account
Abivax SA Sponsored ADR
ABVX Healthcare Biotechnology
- EPS
- −98.8%
- Free cash flow
- −48.3%
- Total debt
- −98.5%
Quarter to June 2026, against a year earlier
86.16
1.98
+2.35%
Follow ABVX
Alert me
Abivax SA Sponsored ADR (ABVX) Book value per share
Abivax SA Sponsored ADR's book value per share at the end of fiscal 2025 was 7.4×, up 963.4% from 0.7× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 5.3×. Over the past ten years it has ranged from 0.4× (fiscal 2022) to 7.4× (fiscal 2025) — the current reading is the highest in ten years. Abivax SA Sponsored ADR ranks 146th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 7.4× | 963.38% |
| FY2024 | 0.7× | (85.86%) |
| FY2023 | 4.9× | 1,141.74% |
| FY2022 | 0.4× | (79.69%) |
| FY2021 | 2.0× | 388.71% |
| FY2020 | 0.4× | (63.19%) |
| FY2019 | 1.1× | (66.38%) |
| FY2018 | 3.2× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 5.3× | (16.04%) |
| Mar 2026 | 6.4× | (14.04%) |
| Dec 2025 | 7.4× | (9.58%) |
| Sep 2025 | 8.2× | — |
| 10 more quarters | Free account |
Against its own ten years
Low 0.4×
High 7.4×
Ten-year median
1.5×
Current reading's percentile
100
Book value per share against peers
| Company | Book value per share |
|---|---|
| PRAX Praxis Precision Medicines, Inc. compare | 46.0× |
| ORKA Oruka Therapeutics, Inc. compare | 17.7× |
| SYRE Spyre Therapeutics, Inc. compare | 11.9× |
| CORT Corcept Therapeutics Incorporated compare | 7.8× |
| ABVX Abivax SA Sponsored ADR | 5.3× |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | 3.3× |
| RYTM Rhythm Pharmaceuticals, Inc. compare | 2.9× |
| AXSM Axsome Therapeutics, Inc. compare | 2.0× |
| CYTK Cytokinetics, Incorporated compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))